Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: As per recommendations, a Peptide Receptor Radionuclide Therapy (PRRT) with Lu-177 DOTATATE course usually consists of 4 cycles. Patients may discontinue a PRRT course early, either due to progression or toxicity. Limited data are available about predictive factors for PRRT early discontinuation.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Julian G
Authors: Gertner J, Groves J, Aziz B, Miah L, Furtado O'Mahony L,
Keywords: prrt,
#2841 Novelties in Primary and Metastatic GEP-NENs Clinical Outcome Investigation
Introduction: Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) WHO classification, using strict cut-offs, should reflect their biological features. In real world, strict cut-offs not adequately segregate prognostic groups, in particular on metastasis (M).
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Milione M
Authors: Kankava K, Maisonneuve P, Mangogna A, Centonze G, Cattaneo L,
Keywords: Gastro-entero-pancreatic neuroendocrine neoplasms, primary tumor, metastasis, Ki-67, mitoses, tumor deposits, clinical outcomes,
Introduction: There is no proven role for adjuvant medical therapy after curative surgery (R0) for GEP-NENs.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Rossi R
Authors: Rossi R, Altomare M, Monteleone M, Prinzi N, Pusceddu S,
Keywords: radical surgery, recurrence, gastro-entero-pancreatic neuroendocrine neoplasms, prognostic factors,
Introduction: Patients with sporadic gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) may exhibit a higher risk of second primary tumors than the general population.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Massironi S
Authors: Massironi S, Campana D, Pusceddu S, Albertelli M, Faggiano A,
Keywords: GEP-NEN, Second primary neoplasm (PMN), Overall survival (OS),
Introduction: Grade 3 (G3) neuroendocrine neoplasms (NEN), arising from the gastro-entero-pancreatic system (GEP), are classified according to WHO 2010 and defined as having a Ki67 of > 20%. However this groups together G3 well differentiated neuroendocrine tumours (WD-NET) with poorly differentiated neuroendocrine carcinomas (PD-NEC). Recently, WHO have proposed a new classification for pancreatic NEN, with sub-division into G3 WD-NET and G3 PD-NEC
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Furnace M
Authors: Furnace M, Muller G, Rundell C, Shah R, Luong T,
Keywords: G3, well-differentiated, poorly differentiated, Ki-67,